Literature DB >> 19433243

Sexual dimorphism in environmental epigenetic programming.

Anne Gabory1, Linda Attig, Claudine Junien.   

Abstract

The phenotype of an individual is the result of complex interactions between genotype and current, past and ancestral environment leading to a lifelong remodelling of our epigenomes. The vast majority of common diseases, including atherosclerosis, diabetes, osteoporosis, asthma, neuropsychological and autoimmune diseases, which often take root in early development, display some degree of sex bias, very marked in some cases. This bias could be explained by the role of sex chromosomes, the different regulatory pathways underlying sexual development of most organs and finally, lifelong fluctuating impact of sex hormones. A substantial proportion of dimorphic genes expression might be under the control of sex-specific epigenetic marks. Environmental factors such as social behaviour, nutrition or chemical compounds can influence, in a gender-related manner, these flexible epigenetic marks during particular spatiotemporal windows of life. Thus, finely tuned developmental program aspects, for each sex, may be more sensitive to specific environmental challenges, particularly during developmental programming and gametogenesis, but also throughout the individual's life under the influence of sex steroid hormones and/or sex chromosomes. An unfavourable programming could thus lead to various defects and different susceptibility to diseases between males and females. Recent studies suggest that this epigenetic programming could be sometimes transmitted to subsequent generations in a sex-specific manner and lead to transgenerational effects (TGEs). This review summarizes the current understanding in the field of epigenetic programming and highlights the importance of studying both sexes in epidemiological protocols or dietary interventions both in humans and in experimental animal models.

Entities:  

Mesh:

Year:  2009        PMID: 19433243     DOI: 10.1016/j.mce.2009.02.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  102 in total

1.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

2.  DLA class II haplotypes show sex-specific associations with primary hypoadrenocorticism in Standard Poodle dogs.

Authors:  Amy E Treeful; Aaron K Rendahl; Steven G Friedenberg
Journal:  Immunogenetics       Date:  2019-04-09       Impact factor: 2.846

Review 3.  Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus.

Authors:  Curt A Sandman; Elysia P Davis; Claudia Buss; Laura M Glynn
Journal:  Neuroendocrinology       Date:  2011-04-15       Impact factor: 4.914

Review 4.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

5.  Fostering in mice induces cardiovascular and metabolic dysfunction in adulthood.

Authors:  Phillippa A Matthews; Anne-Maj Samuelsson; Paul Seed; Joaquim Pombo; Jude A Oben; Lucilla Poston; Paul D Taylor
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

6.  Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers.

Authors:  Shouping Liu; Weiwei Lai; Ying Shi; Na Liu; Lianlian Ouyang; Ziying Zhang; Ling Chen; Xiang Wang; Banglun Qian; Desheng Xiao; Qin Yan; Ya Cao; Shuang Liu; Yongguang Tao
Journal:  NPJ Precis Oncol       Date:  2020-03-03

Review 7.  Influence of environmental exposure on human epigenetic regulation.

Authors:  Carmen J Marsit
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

8.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

9.  Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.

Authors:  Iris M Heid; Peter Henneman; Andrew Hicks; Stefan Coassin; Thomas Winkler; Yurii S Aulchenko; Christian Fuchsberger; Kijoung Song; Marie-France Hivert; Dawn M Waterworth; Nicholas J Timpson; J Brent Richards; John R B Perry; Toshiko Tanaka; Najaf Amin; Barbara Kollerits; Irene Pichler; Ben A Oostra; Barbara Thorand; Rune R Frants; Thomas Illig; Josée Dupuis; Beate Glaser; Tim Spector; Jack Guralnik; Josephine M Egan; Jose C Florez; David M Evans; Nicole Soranzo; Stefania Bandinelli; Olga D Carlson; Timothy M Frayling; Keith Burling; George Davey Smith; Vincent Mooser; Luigi Ferrucci; James B Meigs; Peter Vollenweider; Ko Willems van Dijk; Peter Pramstaller; Florian Kronenberg; Cornelia M van Duijn
Journal:  Atherosclerosis       Date:  2009-12-02       Impact factor: 5.162

10.  Sex differences in fetal growth responses to maternal height and weight.

Authors:  Michelle Lampl; Francesca Gotsch; Juan Pedro Kusanovic; Ricardo Gomez; Jyh Kae Nien; Edward A Frongillo; Roberto Romero
Journal:  Am J Hum Biol       Date:  2010 Jul-Aug       Impact factor: 1.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.